Results 121 to 130 of about 131,822 (267)

Dimensional association between ADHD traits and gray matter volume in young adults: A voxel‐based morphometry study

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
This study examined the association between attention‐deficit/hyperactivity disorder (ADHD) traits and gray matter volume (GMV) in 534 healthy young adults. Higher Hyperactivity/Restlessness scores were associated with greater GMV in the right dorsolateral prefrontal cortex (DLPFC), a region implicated in executive control and behavioral regulation. No
Haruka Asaoka, Michio Takahashi, Kentaro Oba, Hikaru Takeuchi, Yasuyuki Taki   +4 more
wiley   +1 more source

Dystrophinopathy with a DMD exon 49–50 deletion in a female patient who developed schizophrenia: An autopsy case

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Abstract Background Mutations in DMD affect not only muscles but also the brain. Cases of schizophrenia with DMD mutations have been described previously. Although female dystrophinopathy often has a milder phenotype, some affected females also have intellectual disabilities and psychiatric disorders.
Shusei Arafuka, Youta Torii, Ayako Miwa, Itaru Kushima, Hirotaka Sekiguchi, Hiroshige Fujishiro, Chikako Habuchi, Hiroaki Miyahara, Yosuke Kawai, Ran Wei, Katsushi Tokunaga, Norio Ozaki, Mari Yoshida, Shuji Iritani, Yasushi Iwasaki, Masashi Ikeda   +15 more
wiley   +1 more source

Depression vulnerability involves brain activity and connectivity changes consistent with cholinergic deviancy

NeuroImage: Clinical
Behavioral and imaging studies suggests that emotional biases in the perception of faces associated with major depression disorder (MD) may be embedded within a broader sensory processing deficit.
Peter Stiers, Zoe Samara, Kyran J.R. Kuijpers, Elisabeth A.T. Evers, Johannes G. Ramaekers   +4 more
doaj   +1 more source

Preliminary real‐world trends in outpatient revenue following implementation of disease‐modifying therapies in general hospital psychiatry in Japan

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Implementation of anti‐amyloid disease‐modifying therapy (DMT) within a psychiatry‐led dementia care program enabled structural transformation of service delivery in a general hospital setting. A multidisciplinary model integrating psychiatry, neurology, and radiology facilitated coordinated care and safe treatment implementation.
Kyohei Otani, Hiroyuki Ishihara, Tetsu Nakamura, Kana Kawabe   +3 more
wiley   +1 more source

How Prevalent Are Autistic Traits Among Children With Attention-Deficit/Hyperactivity Disorder? A Qualitative Review of the Literature

Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, 2012
Background: Twin, family, and linkage studies have indicated that attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs) share a portion of their heritable etiology.
Uchida Mai, Faraone Stephen V., Joshi Gagan, Spencer Andrea, Kenworthy Tara, Woodworth K. Yvonne, Biederman Joseph   +6 more
doaj   +1 more source

Pediatric catatonia: A case report and review of the management

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Abstract Background Catatonia is when someone does not respond to stimuli or their environment whilst awake. Catatonia can present in a variety of ways, including a change in movement, speech, and behavior. There is limited research on the causes and management of catatonia in an adult population and even more so in the pediatric population.
Alison Thornton, Russell Birkett
wiley   +1 more source

Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Clozapine (CLOZ) is often avoided in treatment‐resistant schizophrenia with comorbid epilepsy due to seizure risks. We report a successful case managed through a cautious CLOZ titration guided by multimodal monitoring, including clinical scales and blood tests such as C‐reactive protein (CRP), CLOZ levels, and anti‐seizure medication (ASM) levels ...
Toru Horinouchi, Mayusa Mito, Toshiyuki Ishikawa, Yuichi Nakamura, Shuhei Ishikawa, Naoki Hashimoto   +5 more
wiley   +1 more source

Cognitive and emotional profiles in children with ASD, ADHD, and comorbid presentations: evidence for a distinct clinical phenotype

Frontiers in Psychiatry
BackgroundAutism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) frequently co-occur, yet their comorbid presentation (ASD+ADHD) remains under- characterized.
Antonio Narzisi, Federica Barbetti, Maddalena Fabbri-Destro, Stefano Berloffa, Pamela Fantozzi, Valentina Viglione, Rosy Muccio, Elena Valente, Ilaria Accorinti, Elisa Foti, Annarita Milone, Ramona Cardillo, Gabriele Masi   +12 more
doaj   +1 more source

L-Tetrahydropalamatine: A Potential New Medication for the Treatment of Cocaine Addiction [PDF]

, 2012
Levo-tetrahydropalmatine (l-THP) is an active constituent of herbal preparations containing plant species of the genera Stephania and Corydalis and has been approved and used in China for a number of clinical indications under the drug name Rotundine ...
Mantsch, John R., Wang​, Jia Bei
core   +1 more source

Association between anticipated follow‐up duration and treatment outcomes in anorexia nervosa: Insights from a Japanese medical prison

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
In a cohort of 149 patients with anorexia nervosa treated in a Japanese medical prison, where follow‐up duration is predetermined by remaining sentence length, we examined its association with treatment outcomes. Longer remaining sentence length was significantly associated with favorable outcomes, defined as clinical improvement enabling transfer back
Wataru Nakagawa, Etsuko Miyamoto, Atsumi Tonai, Marika Okamura, Yusuke Okumura, Takayuki Okada   +5 more
wiley   +1 more source